Interferon, originally detected by its capacity to inhibit viral replication in vitro (1) , has long been suspected to play a role in viral infections in vivo (2) . Thus, it was noted that interferon appeared at the right time and in the right place to limit viral growth (3) . Nevertheless, a simple correlation between the amount of interferon and the severity of a viral disease seems insufficient to make a strong case for interferon as a defense mechanism. With the availability of potent anti-interferon antisera, it became possible to demonstrate more convincingly that interferon may determine viral pathogenicity (4) (5) (6) .
An interesting illustration for this is influenza virus infection in mice carrying the dominant allele Mx. Adult animals with this gene resist the lethal effect of large doses of mouse-adapted influenza viruses, titers of virus grown in their organs remain low, and interferon is hardly detectable (7, 8) . Nevertheless, injection of potent antiinterferon antibodies renders Mx-bearing mice as susceptible to lethal influenza virus infection as non-Mx-bearing mice (8) . That interferon has a protective role in vivo, however, has so far not been demonstrated directly. Because newborn Mx-bearing mice are virtually as susceptible to orthomyxoviruses as their Mx-negative counterparts (9), we were able to determine the efficacy of interferon in protecting newborn mice differing at the Mx locus.
Materials and Methods
Mice. A/J and CBA/J mice were obtained from G. L. Bomholtg~rd, Ry, Denmark. Inbred A2G mice, homozygous for the dominant resistance allele Mx (7) were bred locally. Timed pregnancies of crosses (A2G × CBA/J)F1, heterozygous for Mx, and (A/J × CBA/J)Fa, devoid of Mx, were arranged in our laboratory.
Interferon Treatment. Interferon was induced by Newcastle disease virus in mouse C-243 cells and was partially purified to 1 × 10 T reference units per mg protein, as previously described (10) . Mock interferon was prepared in the same way except that the interferon inducer was omitted. Newborn mice were marked and injected subcutaneously in the interscapular region with 0.05 ml of interferon on days 1, 2, and 3 after birth to give the total amounts of reference units per mouse indicated in the text. Marked controls within each litter were similarly inoculated with mock interferon.
Virus Challenge. Animals were infected intraperitoneally on day 2 after birth. Lethal doses of the following viruses were used: TURH, a hepatotropic influenza A variant, was derived from A/Turkey/England/63 (Havl, Nav3) (11) . Encephalomyocarditis virus (EMC) was passaged in monolayer cultures of L929 cells as described (12) . Vesicular stomatitis virus (VSV), serotype Indiana, was grown and stored as previously described (12) .
Results and Discussion
Newborn mice of crosses (A/J × CBA/J)F1 and (A2G × CBA/J)Fa were used. A/J and CBA/J mice are devoid of Mx, whereas A2G mice are homozygous for Mx. Because A/J and A2G mice are related strains sharing, for example, the major histocompatibility locus (13), there is a considerable overall similarity between the two sets of crosses. Within each litter, some mice were treated with interferon, and others were similarly treated with control material (mock interferon). The challenge viruses used were TURH, to which adult Mx-bearing animals are highly resistant (11) , and EMC and VSV, both of similar virulence for mice bearing Mx or devoid of it (14) .
From the data in Table I , it appears that interferon, even at the highest dosage used (8 × 105 interferon U/mouse), did not protect (A/J × CBA/J)F1 mice from death upon challenge with the influenza virus TURH. This confirms earlier observations on the negligible role played by interferon in influenza virus infection of ordinary mice (5) . In contrast, all (A2G × CBA/J)Fa mice treated with the highest dose of interferon survived, and 10 times less interferon protected almost half of them. With 100 times less interferon, both Mx and non-Mx bearers died, with the difference that death was significantly delayed in presence of Mx (P < 0.001). When no interferon was given, Mx bearers died also somewhat later than their non-Mx counterparts, but this was barely significant. This slight delay of death may have been due to the production of traces of interferon in response to infection. Tables II and III show that the lethal effects of EMC and VSV were inhibited to a similar extent in both sets of mice.
This host gene-dependent difference of interferon action selective for a given virus, demonstrated here in vivo, mirrors faithfully the features observed in vitro. Isolated Mx-bearing cells, such as macrophages (12) * Newborn mice were treated with interferon as indicated in Materials and Methods. They were given 0.05 ml of a dilution of VSV containing 250 mean tissue culture infective doses (as titrated in ~ cells) (12) on day 2 after birth. Deaths were recorded daily. :~ Probability P as indicated in Table I . Our findings have practical implications. Had we used newborn mice to evaluate the protective activity of interferon toward influenza virus, the same preparation judged as showing antiviral activity in Mx-bearing mice would not exhibit any such activity in mice of a different genotype. Furthermore, it is likely that similar interactions between interferon and host genes are important in the expression of nonantiviral effects of interferon, such as effects on delayed type hypersensitivity (20) and cell proliferation (21) . It may be that, in man, host genes affecting interferon action will also prove to be important in determining sensitivity to viral infections and response to interferon therapy.
Summary
The efficacy of interferon in antiviral protection of newborn mice differing at the Mx locus was investigated. Adult mice bearing the allele Mx exhibit a high degree of specific resistance toward lethal challenge with influenza viruses. In contrast, newborn Mx carriers are virtually as susceptible to influenza viruses as newborn mice devoid of Mx. Resistance can be abrogated by treating adult animals with anti-interferon serum. Here, we provide direct evidence of a virus-specific effect of interferon in vivo: newborn mice carrying the resistance gene Mx could be protected against lethal influenza virus infection with doses of interferon that were not protective in the absence of Mx. The efficacy of interferon towards a picornavirus (encephalomyocarditis virus) and a rhabdovirus (vesicular stomatitis virus) was independent of Mx.
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